Search results
Showing 826 to 840 of 1364 results for social care
of medicines and improving patient-reported outcomes, compared with usual care or other intervention in the UK setting? Any explanatory...
This guide outlines the main elements of the interim process and methods for the NICE clinical guideline updates using standing committees pilot programme, including details of the Clinical Guidelines Updates committee, which were agreed by the NICE Board in September 2013
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
Organisation of care:- What is the clinical and cost effectiveness of alternative approaches to organising primary care...
point in the care pathway the views and experiences expressed relate to. As such, it is difficult to fully break down the experience of...
medicines and medicines-related patient safety incidents, compared with usual care or other interventions, in children? Any explanatory...
Selective dorsal rhizotomy for spasticity in cerebral palsy (HTG245)
Evidence-based recommendations on selective dorsal rhizotomy for spasticity in cerebral palsy. This involves cutting nerves in the lower spine that are responsible for muscle rigidity.
View recommendations for HTG245Show all sections
Sections for HTG245
NICE has developed a medtech innovation briefing (MIB) on RT300 for spinal cord injury rehabilitation .
This guideline covers identifying and managing otitis media with effusion (OME), also known as ‘glue ear’, in children younger than 12 years. It aims to improve hearing and quality of life in children with OME.
delivered alone or in combination (in conjunction with standard care) compared with standard care alone for young people...
Recommendation ID NG181/6 Question Is an integrated care system effective at promoting successful progress for people with complex...
Evidence-based recommendations on durvalumab (Imfinzi) for locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation in adults.
Patisiran for treating hereditary transthyretin amyloidosis (HST10)
Evidence-based recommendations on patisiran (Onpattro) for treating hereditary transthyretin amyloidosis in adults with stage 1 and stage 2 polyneuropathy.
to address the needs of older people. It is also unclear if health and social care practitioners fully understand the purpose of the...